ß Thalassaemic trait and systemic lupus erythematosus

Autor Castellino, G, Govoni, M, Padovan, M, Rizzo, N, Trotta, F
Vydáno 2005

Proton magnetic resonance spectroscopy may predict future brain lesions in SLE patients: a functional multi-imaging approach and follow up

Autor Castellino, G, Govoni, M, Padovan, M, Colamussi, P, Borrelli, M, Trotta, F
Vydáno 2005

PL2.2 Pembrolizumab (PEM) in recurrent high-grade glioma (HGG)patients with mismatch repair deficiency (dMMR): an observational study

Autor Caccese, M, Simonelli, M, Fassan, M, Padovan, M, Persico, P, Bellu, L, Dipasquale, A, Gardiman, M, Indraccolo, S, Zagonel, V, Lombardi, G
Vydáno v Neuro Oncol (2019)

OS7.3 Health-related quality of life (HRQoL) evaluation in the REGOMA trial: a randomized, phase II clinical trial analyzing regorafenib activity in relapsed glioblastoma patients

Autor Lombardi, G, Del Bianco, P, Brandes, A, Eoli, M, Rudà, R, Ibrahim, T, Lolli, I, Pace, A, Daniele, B, Pasqualetti, F, Rizzato, S, Bergo, E, Caccese, M, Padovan, M, Soffietti, R, De Salvo, G, Zagonel, V
Vydáno v Neuro Oncol (2019)